Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26

S. Karim, K. Ding, P. Bradbury, P. Ellis, N. Mittman, X. Xiaoqun Sun, M. Millward, G. Liu, S. Sun, M. R. Stockler, V. Cohen, N. Blais, R. Sangha, M. Boyer, R. Sasidharan, C. Lee, F. A. Shepherd, G. Goss, L. Seymour, N. B. Leighl

Research output: Contribution to journal › Abstract/Meeting Abstract

Original languageEnglish
Number of pages1
JournalAnnals of Oncology
Volume28
Publication statusPublished - Sep 2017
Externally publishedYes
Event42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain
Duration: 8 Sep 2017 → 12 Sep 2017

Cite this

Karim, S., Ding, K., Bradbury, P., Ellis, P., Mittman, N., Sun, X. X., ... Leighl, N. B. (2017). Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26. Annals of Oncology, 28.
Karim, S. ; Ding, K. ; Bradbury, P. ; Ellis, P. ; Mittman, N. ; Sun, X. Xiaoqun ; Millward, M. ; Liu, G. ; Sun, S. ; Stockler, M. R. ; Cohen, V. ; Blais, N. ; Sangha, R. ; Boyer, M. ; Sasidharan, R. ; Lee, C. ; Shepherd, F. A. ; Goss, G. ; Seymour, L. ; Leighl, N. B. / Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC : CCTG BR.26. In: Annals of Oncology. 2017 ; Vol. 28.
@article{9603639fb19b44c1a2fe2acf68d397a1,
title = "Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26",
author = "S. Karim and K. Ding and P. Bradbury and P. Ellis and N. Mittman and Sun, {X. Xiaoqun} and M. Millward and G. Liu and S. Sun and Stockler, {M. R.} and V. Cohen and N. Blais and R. Sangha and M. Boyer and R. Sasidharan and C. Lee and Shepherd, {F. A.} and G. Goss and L. Seymour and Leighl, {N. B.}",
year = "2017",
month = "9",
language = "English",
volume = "28",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "OXFORD UNIV PRESS UNITED KINGDOM",

}

Karim, S, Ding, K, Bradbury, P, Ellis, P, Mittman, N, Sun, XX, Millward, M, Liu, G, Sun, S, Stockler, MR, Cohen, V, Blais, N, Sangha, R, Boyer, M, Sasidharan, R, Lee, C, Shepherd, FA, Goss, G, Seymour, L & Leighl, NB 2017, 'Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26' Annals of Oncology, vol. 28.

Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC : CCTG BR.26. / Karim, S.; Ding, K.; Bradbury, P.; Ellis, P.; Mittman, N.; Sun, X. Xiaoqun; Millward, M.; Liu, G.; Sun, S.; Stockler, M. R.; Cohen, V.; Blais, N.; Sangha, R.; Boyer, M.; Sasidharan, R.; Lee, C.; Shepherd, F. A.; Goss, G.; Seymour, L.; Leighl, N. B.

In: Annals of Oncology, Vol. 28, 09.2017.

Research output: Contribution to journal › Abstract/Meeting Abstract

TY - JOUR

T1 - Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC

T2 - CCTG BR.26

AU - Karim, S.

AU - Ding, K.

AU - Bradbury, P.

AU - Ellis, P.

AU - Mittman, N.

AU - Sun, X. Xiaoqun

AU - Millward, M.

AU - Liu, G.

AU - Sun, S.

AU - Stockler, M. R.

AU - Cohen, V.

AU - Blais, N.

AU - Sangha, R.

AU - Boyer, M.

AU - Sasidharan, R.

AU - Lee, C.

AU - Shepherd, F. A.

AU - Goss, G.

AU - Seymour, L.

AU - Leighl, N. B.

PY - 2017/9

Y1 - 2017/9

M3 - Abstract/Meeting Abstract

VL - 28

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -

Karim S, Ding K, Bradbury P, Ellis P, Mittman N, Sun XX et al. Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26. Annals of Oncology. 2017 Sep;28.